Argent Large Cap ETF (ABIG)
Live price chart, market sentiment, and community perspectives for Argent Large Cap ETF (NASDAQ: ABIG).
Live price chart, market sentiment, and community perspectives for Argent Large Cap ETF (NASDAQ: ABIG).
On our desk, looking at ABIG's recent data, we notice Jane Street establishing a new position valued around $375,000 during Q2 alongside Moneta Group upping their stake by 23.5%. However, with an average daily volume of roughly 3,516 shares, liquidity remains a key constraint for larger block executions without moving the spread. Market sentiment is quietly constructive, but retail engagement remains low.
Evaluating the underlying methodology of the fund, ABIG filters down from an investable universe of the 1,000 largest U.S. stocks using a bottom-up fundamental approach. They target 30 to 35 holdings defined as 'Enduring Businesses' showing growing cash flows and durable competitive advantages. The expense ratio is fixed at 0.49%, which is standard for an actively managed large-cap concentrated ETF launched in April 2025.
From a risk management standpoint, short interest in ABIG dropped significantly by 44.4% down to 377 shares as of July 31st, putting the short-interest ratio at a minimal 0.1 days with essentially 0.0% of shares shorted. This tells me there is virtually zero short-squeeze thesis here; price movement will be dictated strictly by top holdings performance and macro large-cap sentiment.
Analyzing ABIG's structural details, the fund trades on NASDAQ with assets under management resting around $37.64M and a trailing twelve-month yield of 0.09% with irregular distributions. Given the 52-week price range of $28.47 to $36.42, downside protection relies heavily on the quality of the 32 portfolio companies weathering macroeconomic volatility.
Reviewing the trailing performance metrics relative to passive benchmarks, a $10,000 investment in ABIG at inception grew to an NAV of roughly $13,731 by mid-2026, which sits below the Russell 1000 Total Return Index ($15,357) and Russell 3000 Total Return Index ($15,419) over the same timeframe. Active share is high, but outperformance versus broad indices requires close monitoring of their concentrated holdings.
Explore plasma cleansing, somatic organ swaps, and BCI.